The Medical Advisor

OneDayMD • The Medical Advisor A single starting point for exploring OneDayMD's health, wellness, longevity, nutrition, cancer, metabolic medicine, emerging therapies and digital-health research. Quick Answer OneDayMD is an independent health-information and research-synthesis platform covering conventional medicine, integrative health, longevity, nutrition, supplements, metabolic medicine, cancer research, emerging therapies and digital health. This Master Guide is the site's central navigation page: use it to find the right topic hub, then move from a broad guide to the specific evidence, study, therapy, supplement, condition or research question you are investigating. On this page Start Here · Core Health Hubs · Cancer & Oncology · Nutrition & Supplements · Longevity · GLP-1 & Metabolic Health · DMSO ·...

Medically & Technically Reviewed by: OneDayMD Editorial Team | Originally Published: August 9, 2026 | Updated: September 2026 Quick Answer There is no single "best" smart glasses for visual impairment in 2026 — the right pick depends on how much usable vision remains. For low vision (residual central vision from macular degeneration, diabetic retinopathy, or Stargardt disease), medical-grade enhancers like eSight Go ($4,950) or Acesight VR digitally magnify and boost contrast. For blind or near-blind users, AI-interpretation glasses like Envision Glasses ($2,499), Ally Solos (from $399), or a clip-on OrCam MyEye 3 Pro (remaining dealer stock, $3,689–$4,490) read text and describe scenes aloud. The cheapest mainstream option is Meta's expanding AI-glasses lineup — Ray-Ban Meta, Meta Glasses (Adventurer/Fury), and Meta Glasses by Kylie — starting at $299, which isn't purpose-built for accessibility but has become a popular everyday alternative thanks t...

GLP-1 vs GLP-2 : Both are glucagon-like peptides made from the same proglucagon precursor, but they are not interchangeable hormones. GLP-1 has become a major metabolic drug target because it can reduce appetite, improve glucose control and promote weight loss. GLP-2 is much more strongly associated with intestinal growth, nutrient absorption, barrier function and adaptation. That difference is now attracting attention as researchers explore whether combining GLP-1 and GLP-2 receptor activity could create a new approach to obesity and metabolic disease. Bottom line: GLP-1 is primarily a metabolic and appetite-regulating signal ; GLP-2 is primarily an intestinal growth and adaptation signal . GLP-2 is not simply a stronger or newer version of GLP-1. The two hormones have distinct receptors, biological actions and established clinical applications. Updated: September 20, 2026 In this guide What are GLP-1 and GLP-2? GLP-1 vs GLP-2: side-by-side comparison How GLP-1 affe...